PharmaCom BioVet

PharmaCom BioVet is a veterinary healthcare company that specialized in advanced oncology treatments for companion animals, particularly dogs and cats. The company's primary focus was the development and implementation of complex medical procedures such as bone marrow transplantation and liquid brachytherapy for treating lymphoma and other aggressive cancers. Headquartered in Raleigh, North Carolina, PharmaCom BioVet aimed to establish a network of specialized veterinary oncology centers across the United States. The company also explored the development of therapeutic compounds, including histone deacetylase inhibitors, to address specific canine cancers like hemangiosarcoma. Although the company was active in the late 2000s, it has since become largely inactive, with its stock trading at nominal values on the OTC market.